Real-World Outcomes of Anti-VEGF Therapy in DME

Thomas A. Ciulla, MD, MBA

Show Description +

Thomas A. Ciulla, MD, MBA, reviews his presentation from the 2017 American Society of Retina Specialists meeting. In his research with David F. Williams, MD, MBA, Dr. Ciulla determined that patients with diabetic macular edema (DME) treated in the real-world with anti-VEGF therapy have consistently poorer outcomes in comparison with those treated in randomized clinical trials.

Posted: 8/09/2017

Keywords:

Anti-VEGF

Up Next

Name: Real-World Outcomes of Anti-VEGF Therapy in DME
Uploaded: 2017-08-09T10:22:00+00:00
Description: Thomas A. Ciulla, MD, MBA, reviews his presentation from the 2017 American Society of Retina Specialists meeting. In his research with David F. Williams, MD, MBA, Dr. Ciulla determined that patients with diabetic macular edema (DME) treated in the real-world with anti-VEGF therapy have consistently poorer outcomes in comparison with those treated in randomized clinical trials.